Abstract:[Purpose] To investigate the frequency of microsatellite instability (MSI) in sporadic multiple primary colorectal carcinomas (MCRC) and to assess the relationship between MSI and the prognosis of sporadic MCRC or the occurrence of metachronous MCRC. [Methods] From 1985 to 2000, 124 paraffinembedded specimens from 70 sporadic MCRC patients with data integrity and 35 specimens from sporadic single colorectal cancer patients followed up over 3 years were available to determine MSI.DNA of these specimens was examined for two microsatellite marks (BAT25 and BAT26).Microsatellite instability phenotype was defined as alterations in both loci. MSI and clinicopathologic parameters were compared by χ2 test. [Results] In sporadic MCRC, 32 carcinomas(25.8%) in 21 patients(30.0%) showed MSIH. While only 2 carcinomas showed MSIH(5.7%) in sporadic single colorectal carcinomas(25.8% vs. 5.7%, P=0.01). MSIH was detected with higher frequency in metachronous carcinomas than that in synchronous carcinomas(36.7% vs. 15.6%, P=0.007). Positive rate in young patients less than 40 years old was higher than that in more than 40 years old(53.8% vs. 22.5%, P=0.015), and that in rightsided colon was higher than that in left sided colon(41.2% vs. 15.1%, P=0.001). The positive rates of MSIH in Dukes'A, B, C and D were 25.0%, 33.3%, 22.2% and 11.1% respectively(P0.05). The positive rate of MSIH in high differentiation adenocarcinomas was 20.0%, 25.9% in moderate differentiation adenocarcinomas, 21.1% in low differentiation adenocarcinomas, 31.6% inmucinous adenocarcinomas(P0.05). Mean followup period was 61 months(range 6~209, median 46). [Conclusions] MSI may be regarded as an independent and important risk factor for predicting occurrence of metachronous of MCRC. MSI may be suitable as a marker for predicting the prognosis of sporadic MCRC.

Microsatellite instability and its relation with the expression of p53 protein in sporadic colorectal carcinoma

Microsatellite Alteration and Its Characteristics in Colorectal Carcinoma

[P53 Mutations in Sporadic Colorectal Cancers with Microsatellite Instability].

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

Expressions of p53 and hMSH2 in colon carcinoma

Expression of MMR and mutated p53 in sporadic colorectal carcinoma

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

[Alterations of P53 Gene and Microsatellite Instability in Ulcerative Colitis and Ulcerative Colitis-Associated Colorectal Cancer].

Relationship between microsatellite instability and clinicopathological features and prognosis in sporadic colorectal cancer

Microsatellite instability in sporadic colorectal cancer and its relationship with clinicopathological features

Association of Microsatellite Instability with Clinicopathological Features of Sporadic Colorectal Cancer

Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability

Expression of Hmsh2, Hmlh1 and P53 in the Sporadic Colorectal Carcinoma

Microsatellite Instability of Sporadic Colorectal Carcinomas and Its Clinicopathological Significance

The Expression and Importance of P53 Protein in Colorectal Carcinoma

Expression of Hmlh1 and P53 in Sporadic Colorectal Carcinoma and Colorectal Adenoma

Expression and clinical significance of survivin protein and p53 in colorectal adenocarcinoma

Gene mutation and protein expression of p53 in multiple colorectal cancers

Microsatellite Instability in Sporadic Multiple Primary Colorectal Carcinoma

Expression and significance of Her-2,P53 and Ki-67 in colorectal cancer

Expression and Clinical Significance of MDM2 and p53 in Colorectal Carcinoma